Only 9.5% of people in low-income countries have received a single dose of the vaccine. Cuba has a comprehensive plan to support vaccine distribution in the global south to make sure none are left behind

Cuba and Vietnam share a rich history of anti-imperialist struggles and are living examples of the daily battle against US hegemony. During the pandemic, they are paving the way for South-South solidarity and enhancing local production, a must for a self-reliant Global South

Gloria La Riva was in Cuba speaking to healthcare professionals about the island’s impressive COVID-19 vaccination campaign and how they tackled the latest wave of cases from the Delta variant

According to the Cuban Public Health Ministry, as of October 12, 6,500,743 Cubans have been fully vaccinated against COVID-19 with its own vaccines. The figure represents 58.1% of the country’s entire population

Today we look at 2 months of Colombia’s National Strike, the release of activists Samar Badawi and Nassima al-Sadah from prison in Saudi Arabia, and more

Two new vaccines, both developed in Cuba, have shown remarkable efficacy in clinical trials. It is crucial to remember that Cuba developed these vaccines even as it continues to suffer under the crippling blockade imposed by the US.

Today we look at the UN’s annual report on Children and Armed Conflict, the final trials of Cuba’s Abdala and Soberana 02 vaccines, and more

The Abdala vaccine showed 92.28% efficacy with three doses during the third phase of clinical trials and the Soberana 02 vaccine showed 62% efficacy with just two of its three doses

With its development of five COVID-19 vaccines and the promise of sharing know-how with developing countries, Cuba has remained faithful to Che Guevara’s values of international solidarity and people-oriented medicine

Last week, the Venezuelan government announced that the Union Bank of Switzerland blocked its latest payments of 10 million USD towards the COVAX initiative for acquiring COVID-19 vaccines

Organizations in Italy have called for a mobilization at the same time as the G20 Health Summit to call on global leaders to prioritize public health over profits and guarantee equal vaccine access

In previous trials, the Soberana 02 vaccine candidate generated antibody response in about 80% of the people who were administered two doses